Global genomic surveillance of monkeypox virus.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
23 Oct 2024
Historique:
received: 06 03 2024
accepted: 21 10 2024
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 23 10 2024
Statut: aheadofprint

Résumé

Monkeypox virus (MPXV) is endemic in Western and Central Africa and, in May 2022, a clade IIb lineage (B.1) caused a global outbreak outside Africa, resulting in its detection in 116 countries/territories. To understand the global phylogenetics of MPXV, we analysed all available MPXV sequences, including 10,670 sequences from 65 countries collected between 1958 and 2024. Our analysis reveals high mobility of clade I viruses within Central Africa, sustained human-to-human transmission of clade IIb lineage A viruses within the Eastern Mediterranean region, and distinct mutational signatures that can distinguish sustained human-to-human from animal-to-animal transmission. Moreover, distinct clade I sequences from Sudan suggest local MPXV circulation in areas of Eastern Africa over the past four decades. Our study underscores the importance of genomic surveillance in tracking spatiotemporal dynamics of MXPV clades and the need to strengthen such surveillance, including in some parts of Eastern Africa.

Identifiants

pubmed: 39442559
doi: 10.1038/s41591-024-03370-3
pii: 10.1038/s41591-024-03370-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.

Auteurs

James R Otieno (JR)

World Health Organization, Geneva, Switzerland.

Christopher Ruis (C)

World Health Organization, Geneva, Switzerland.
Victor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.
Cambridge Centre for AI in Medicine, University of Cambridge, Cambridge, UK.
Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.

Anyebe B Onoja (AB)

World Health Organization, Geneva, Switzerland.

Krutika Kuppalli (K)

World Health Organization, Geneva, Switzerland.
Department of Medicine, University of Texas Southwestern, Dallas, Texas, USA.
Peter O'Donnell Jr School of Public Health, University of Texas Southwestern, Dallas, Texas, USA.

Ana Hoxha (A)

World Health Organization, Geneva, Switzerland.

Andreas Nitsche (A)

ZBS - Highly Pathogenic Viruses, German Consultant Laboratory for Poxviruses, WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany.

Annika Brinkmann (A)

ZBS - Highly Pathogenic Viruses, German Consultant Laboratory for Poxviruses, WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany.

Janine Michel (J)

ZBS - Highly Pathogenic Viruses, German Consultant Laboratory for Poxviruses, WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany.

Placide Mbala-Kingebeni (P)

National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo.
University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Daniel Mukadi-Bamuleka (D)

University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
National Institute for Biomedical Research, Goma, Democratic Republic of the Congo.

Muntasir Mohammed Osman (MM)

Health Emergencies and Epidemics Control, Federal Ministry of Health, Khartoum, Sudan.

Hanadi Hussein (H)

Health Emergencies and Epidemics Control, Federal Ministry of Health, Khartoum, Sudan.

Muhammad Ali Raja (MA)

World Health Organization Country Office, Red Sea State - Port Sudan, <City>, Republic of the Sudan.

Richard Fotsing (R)

World Health Organization Country Office, Kinshasa, Democratic Republic of the Congo.

Belinda L Herring (BL)

World Health Organization Regional Office for Africa, Brazzaville, Republic of the Congo.

Mory Keita (M)

World Health Organization Regional Office for Africa, Brazzaville, Republic of the Congo.

Jairo Mendez Rico (JM)

World Health Organization Regional Office for the Americas, <City>, Washington, USA.

Lionel Gresh (L)

World Health Organization Regional Office for the Americas, <City>, Washington, USA.

Amal Barakat (A)

World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.

Victoria Katawera (V)

World Health Organization Regional Office for the Western Pacific, Manila, the Philippines.

Karen Nahapetyan (K)

World Health Organization Regional Office for Europe, Copenhagen, Denmark.

Dhamari Naidoo (D)

World Health Organization Regional Office for South East Asia, New Delhi, India.

R Andres Floto (RA)

Victor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.
Cambridge Centre for AI in Medicine, University of Cambridge, Cambridge, UK.
Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, UK.

Jane Cunningham (J)

World Health Organization, Geneva, Switzerland.

Maria D Van Kerkhove (MD)

World Health Organization, Geneva, Switzerland.

Rosamund Lewis (R)

World Health Organization, Geneva, Switzerland.

Lorenzo Subissi (L)

World Health Organization, Geneva, Switzerland. subissil@who.int.

Classifications MeSH